Modular smart molecules for PSMA-targeted chemotherapy

FP Olatunji, M Pun, JW Herman, O Romero… - Molecular cancer …, 2022 - AACR
New targeted chemotherapeutics are urgently needed to minimize off-target toxicity and
reduce the high-mortality rate associated with metastatic prostate cancer. Herein, we report …

Modular Smart Molecules for PSMA-Targeted Chemotherapy

FP Olatunji, M Pun, JW Herman, O Romero… - Molecular Cancer …, 2022 - AACR
New targeted chemotherapeutics are urgently needed to minimize off-target toxicity and
reduce the high-mortality rate associated with metastatic prostate cancer. Herein, we report …

[PDF][PDF] Modular Smart Molecules for PSMA-Targeted Chemotherapy

FP Olatunji, M Pun, JW Herman, O Romero… - s3.wp.wsu.edu
New targeted chemotherapeutics are urgently needed to minimize off-target toxicity and
reduce the high mortality rate associated with metastatic prostate cancer (PCa). Herein, we …

Modular Smart Molecules for PSMA-Targeted Chemotherapy

FP Olatunji, M Pun, JW Herman… - Molecular cancer …, 2022 - pubmed.ncbi.nlm.nih.gov
New targeted chemotherapeutics are urgently needed to minimize off-target toxicity and
reduce the high-mortality rate associated with metastatic prostate cancer. Herein, we report …

Modular Smart Molecules for PSMA-Targeted Chemotherapy.

FP Olatunji, M Pun, JW Herman, O Romero… - Molecular Cancer …, 2022 - europepmc.org
New targeted chemotherapeutics are urgently needed to minimize off-target toxicity and
reduce the high mortality rate associated with metastatic prostate cancer (PCa). Herein, we …

[HTML][HTML] Modular Smart Molecules for PSMA-Targeted Chemotherapy

FP Olatunji, M Pun, JW Herman, O Romero… - Molecular cancer …, 2022 - ncbi.nlm.nih.gov
New targeted chemotherapeutics are urgently needed to minimize off-target toxicity and
reduce the high mortality rate associated with metastatic prostate cancer (PCa). Herein, we …